| Altavista Medical Center | |
|
1280a Main St Altavista VA 24517-1458 | |
| (434) 309-1165 | |
| Not Available |
| Full Name | Altavista Medical Center |
|---|---|
| Speciality | Family Medicine |
| Location | 1280a Main St, Altavista, Virginia |
| Authorized Official Name and Position | Arthur Leavitt (VP PHYSICIAN PRACTICE MANAGEMENT) |
| Authorized Official Contact | 4342003656 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Altavista Medical Center 1204 Fenwick Dr Lynchburg VA 24502-2112 Ph: () - | Altavista Medical Center 1280a Main St Altavista VA 24517-1458 Ph: (434) 309-1165 |
| NPI Number | 1619912441 |
|---|---|
| Provider Enumeration Date | 06/17/2006 |
| Last Update Date | 04/25/2012 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619912441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
News Archive
Engineers at the University of California San Diego have developed the first flexible wearable device capable of monitoring both biochemical and electric signals in the human body.
Scientists from the Max F. Perutz Laboratories (MFPL) of the University of Vienna and the Medical University of Vienna have identified a specific enzyme, histone deacetylase 2 (HDAC2), as essential for brain development. The findings published in Development are important to advance the development of new drugs to treat neurological diseases.
The uproar that began last year when the U.S. Preventive Services Task Force stated that doctors should no longer offer regular prostate-cancer tests to healthy men continued this week when the task force released their final report. Overall, they stuck to their guns, stating that a blood test commonly used to screen for prostate cancer, the PSA test, causes more harm than good - it leads men to receive unnecessary, and sometimes even dangerous, treatments.
Alimera Sciences, Inc. (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has resubmitted its New Drug Application for ILUVIEN® to the U.S. Food and Drug Administration (FDA).
Many times, people with heart disease have few visible symptoms. This is one of the reasons why heart disease is the number one killer for both men and women in America. Saint Louis University and SLUCare offer a non-invasive test that could save your life or the life of someone you love.
› Verified 6 days ago
Altavista Medical Center Rhc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1280a Main St, Altavista, VA 24517 Phone: 434-309-1165 |